Cargando…

A comparative analysis of depressive-like behavior: Exploring sex-related differences and insights

Profiling the variability related to the estrous cycle is essential for assessing depressive-like behavior and screening drugs. This study compares circulating plasma corticosterone levels [CORT] and behavioral alterations in mice exposed to sucrose preference, forced swimming, and tail suspension t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Ana Carolina Cavalcante, Moreira, Caroline Vitória de Lima, Prado, Camila Carlos, Silva, Luan Silvestro Bianchini, Costa, Rafael Fernandes, Arikawe, Adesina Paul, Pedrino, Gustavo Rodrigues, Costa, Elson Alves, Silva, Osmar Nascimento, Napolitano, Hamilton Barbosa, Oliveira-Silva, Iranse, Fajemiroye, James Oluwagbamigbe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686438/
https://www.ncbi.nlm.nih.gov/pubmed/38019810
http://dx.doi.org/10.1371/journal.pone.0294904
Descripción
Sumario:Profiling the variability related to the estrous cycle is essential for assessing depressive-like behavior and screening drugs. This study compares circulating plasma corticosterone levels [CORT] and behavioral alterations in mice exposed to sucrose preference, forced swimming, and tail suspension tests (SPT, FST, and TST, respectively). While SPT exposure did not significantly alter [CORT], FST and TST showed notable changes. Mice in the TST exhibited increased movement and decreased immobility time compared to FST, suggesting a lower likelihood of depressive-like behavior in male mice. Notably, during the proestrus phase, female mice displayed the highest tendency for depressive-like behavior and elevated [CORT], but similar response to antidepressants (imipramine and fluoxetine). The inherent stress of the FST and TST tasks appears to influence [CORT] as well as depressant and antidepressant effects. These comparisons provide valuable insights for further behavioral phenotyping, model sensitivity assessment, and deepen our neurobiological understanding of depression in the context of drug screening.